Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Mira Pharmaceuticals Inc’s stock clocked out at $0.93, up 2.21% from its previous closing price of $0.91. In other words, the price has increased by $2.21 from its previous closing price. On the day, 0.53 million shares were traded.
Ratios:
To gain a deeper understanding of MIRA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.11 and its Current Ratio is at 6.11. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 19 ’24 when Aminov Erez sold 55,410 shares for $1.39 per share. The transaction valued at 77,020 led to the insider holds 1,105,790 shares of the business.
Aminov Erez sold 44,590 shares of MIRA for $56,629 on Nov 20 ’24. The Chief Executive Officer now owns 1,061,200 shares after completing the transaction at $1.27 per share. On Nov 19 ’24, another insider, Erez Aminov, who serves as the Affiliate of the company, bought 100,000 shares for $1.41 each.
Stock Price History:
Over the past 52 weeks, MIRA has reached a high of $5.01, while it has fallen to a 52-week low of $0.51. The 50-Day Moving Average of the stock is -18.69%, while the 200-Day Moving Average is calculated to be -27.56%.
Shares Statistics:
A total of 16.27M shares are outstanding, with a floating share count of 12.09M. Insiders hold about 33.28% of the company’s shares, while institutions hold 6.76% stake in the company.
